Status:
UNKNOWN
Primary Graft Dysfunction Score in Lung Transplantation
Lead Sponsor:
Assoc.-Prof. Dr. Konrad Hoetzenecker, PhD
Conditions:
Lung Transplant; Complications
Eligibility:
All Genders
18-80 years
Brief Summary
The validity of several functional parameters, which could be included in a new PGD scoring system, will be tested in a prospective pilot study of 80 consecutive bilateral lung transplant recipients i...
Eligibility Criteria
Inclusion
- Double lung transplantation for primary pulmonary hypertension (PPH), Fibrosis, cystic fibrosis (CF), Emphysema
- No restrictions regarding donor lungs (marginal donors, EVLP possible)
- No restrictions regarding size reduction (anatomic wedge resections, three lobar, lobar transplantations)
Exclusion
- Single-lung transplantation
- Heart-lung transplantation
- Re-transplantation
- Patients with bridge-to-transplantation with a mechanical assist device (extra-corporal membrane oxygenation (v/v, v/a), PA/LA Novalung, ILAactive, ILA)
- Clinical situations leading to inaccurate PiCCO measurements e.g. intracardiac shunts, significant tricuspid regurgitation, cooling
- No access to the femoral artery possible
- Severe postoperative hemorrhage, which leads to hematothorax and makes revision surgery necessary
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03276403
Start Date
November 1 2016
End Date
March 1 2018
Last Update
September 8 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090
2
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4